文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

肥胖的慢性化以及早期治疗对于降低心血管代谢风险和改善身体成分的重要性。

Chronicity of obesity and the importance of early treatment to reduce cardiometabolic risk and improve body composition.

作者信息

Christensen Sandra, Nelson Christina

机构信息

Integrative Medical Weight Management, Seattle, WA, USA.

Overlake Bariatric and Metabolic Weight Loss Clinic, Bellevue, WA, USA.

出版信息

Obes Pillars. 2025 Apr 2;15:100175. doi: 10.1016/j.obpill.2025.100175. eCollection 2025 Sep.


DOI:10.1016/j.obpill.2025.100175
PMID:40487673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12141096/
Abstract

BACKGROUND: Obesity is a chronic disease that affects millions of adults and children globally. Obesity is particularly prevalent in the US and is associated with adiposity-related complications, such as cardiovascular disease, hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cancer, and reduced quality of life. The Obesity Medicine Association's 4 pillars of obesity treatment are nutrition therapy, physical activity, behavioral counseling, and medical interventions, the latter of which includes pharmacotherapy, complication management, and bariatric procedures. Long-term obesity treatment using these treatment modalities guides chronic disease management to achieve sustained weight reduction, improved health outcomes, and improved quality of life. METHODS: In this narrative review, we focus on obesity as a chronic disease and the importance of chronic disease management. We also review body composition changes that occur with obesity and the goals of obesity treatment as they relate to body composition. Finally, obesity treatment modalities and recommendations are discussed. RESULTS: Individuals with pre-obesity, which is a state of early obesity, often progress to obesity. Further, individuals with obesity attempting weight reduction frequently reduce weight and experience subsequent weight recurrence, highlighting the chronic nature of obesity. Pathophysiologic factors such as the location and degree of adiposity, as well as the health of adipose tissue, impact the risk factors, outcomes, and treatment options for patients with obesity. Treatment modalities and appointment frequency can be personalized to individualize treatment and maximize adiposity reduction and preservation of lean body mass. CONCLUSIONS: Early and lifelong treatment is critical for maintaining lean body mass as well as preventing weight recurrence and increased adiposity. Obesity treatment should reduce adiposity, preserve lean muscle, and maintain bone health. Weight-reduction maintenance that can be sustained long-term is also a critical component of chronic disease management.

摘要

背景:肥胖是一种慢性病,全球数以百万计的成年人和儿童受其影响。肥胖在美国尤为普遍,并与肥胖相关并发症有关,如心血管疾病、高血压、2型糖尿病、血脂异常、阻塞性睡眠呼吸暂停、癌症以及生活质量下降。肥胖医学协会的肥胖治疗四大支柱是营养治疗、体育活动、行为咨询和医学干预,后者包括药物治疗、并发症管理和减肥手术。使用这些治疗方式进行长期肥胖治疗可指导慢性病管理,以实现持续减重、改善健康结果和提高生活质量。 方法:在本篇叙述性综述中,我们重点关注肥胖作为一种慢性病以及慢性病管理的重要性。我们还回顾了肥胖时发生的身体成分变化以及与身体成分相关的肥胖治疗目标。最后,讨论了肥胖治疗方式和建议。 结果:肥胖前期个体(即早期肥胖状态)往往会发展为肥胖。此外,试图减重的肥胖个体经常体重下降,但随后又会复发,这突出了肥胖的慢性本质。诸如肥胖的部位和程度以及脂肪组织健康等病理生理因素会影响肥胖患者的危险因素、结局和治疗选择。治疗方式和预约频率可以个性化,以实现个体化治疗,并最大程度地减少肥胖和保留瘦体重。 结论:早期和终身治疗对于维持瘦体重以及预防体重复发和肥胖增加至关重要。肥胖治疗应减少肥胖、保留瘦肌肉并维持骨骼健康。能够长期维持的体重减轻也是慢性病管理的关键组成部分。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b4/12141096/2e0d739a1858/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b4/12141096/2e0d739a1858/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12b4/12141096/2e0d739a1858/ga1.jpg

相似文献

[1]
Chronicity of obesity and the importance of early treatment to reduce cardiometabolic risk and improve body composition.

Obes Pillars. 2025-4-2

[2]
Roux-en-Y Gastric Bypass

2025-1

[3]
[Pharmacological therapy of obesity].

G Ital Cardiol (Rome). 2008-4

[4]
Visceral adiposity and inflammatory bowel disease.

Int J Colorectal Dis. 2021-11

[5]
An overview of obesity-related complications: The epidemiological evidence linking body weight and other markers of obesity to adverse health outcomes.

Diabetes Obes Metab. 2025-4

[6]
Obesity Management in Adults: A Review.

JAMA. 2023-11-28

[7]
[Expert consensus on the diagnosis and treatment of obstructive sleep apnea in women].

Zhonghua Jie He He Hu Xi Za Zhi. 2024-6-12

[8]
Intragastric Balloon

2025-1

[9]
Single-Anastomosis Duodeno-Ileal Bypass

2025-1

[10]
Feeding the critically ill obese patient: a systematic review protocol.

JBI Database System Rev Implement Rep. 2015-10

引用本文的文献

[1]
The association between diabetes and head and neck squamous cell carcinoma: evidence from clinical cohort and bioinformatics analyses.

Front Genet. 2025-8-13

本文引用的文献

[1]
Adipose tissue retains an epigenetic memory of obesity after weight loss.

Nature. 2024-12

[2]
Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis.

N Engl J Med. 2024-10-31

[3]
Strategies for minimizing muscle loss during use of incretin-mimetic drugs for treatment of obesity.

Obes Rev. 2025-1

[4]
Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials.

Lancet. 2024-9-7

[5]
Efficacy and safety of once-weekly semaglutide 2·4 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial.

Lancet Diabetes Endocrinol. 2024-9

[6]
Bone Health After Exercise Alone, GLP-1 Receptor Agonist Treatment, or Combination Treatment: A Secondary Analysis of a Randomized Clinical Trial.

JAMA Netw Open. 2024-6-3

[7]
Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity.

N Engl J Med. 2024-10-3

[8]
Metabolic dysfunction-associated steatotic liver disease heterogeneity: Need of subtyping.

World J Gastrointest Pathophysiol. 2024-5-24

[9]
Body Roundness Index and All-Cause Mortality Among US Adults.

JAMA Netw Open. 2024-6-3

[10]
Bariatric surgery for spontaneous ovulation in women living with polycystic ovary syndrome: the BAMBINI multicentre, open-label, randomised controlled trial.

Lancet. 2024-6-8

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索